BOT Natunola Agritech, Inc.

QUALIFIES FOR COVETED "BROAD SPECTRUM" LABEL QUEBEC CITY, Dec. 7, 2011 /CNW/ - Botaneco Corp. ("Botaneco" or the "Corporation") , announces that several of its natural and traditional Hydresia® oleosome sunscreen prototypes have successfully completed the necessary testing required to meet the new U.S. Food and Drug Administration (FDA) requirements for sunscreen labeling that go into effect in 2012.  The testing included a successful "critical wavelength" study which will allow sunscreen marketers utilizing Botaneco's Hydresia® oleosomes to be labeled "Broad Spectrum" indicating protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays. Current labeling requirements on sunscreens deal almost exclusively with protection against sunburn, which is primarily caused by UVB radiation from the sun, and do not address UVA radiation, which contributes to skin cancer and early skin aging. On June 14, 2011 the FDA issued a statement that, for the first time, products claiming sun protection will have to indicate whether a product also protects against UVA.  Sunscreens that have not successfully completed the FDA required "critical wavelength" study indicating proper UVA protection can not claim the "Broad Spectrum" label.  This will require marketers to place a warning label indicating the product does not help to prevent skin cancer or early skin aging. "Marketers who wish to have a natural sunscreen with a Broad Spectrum label claiming to reduce the risk of skin cancer and early skin aging can implement Hydresia® into their formulations.  We have been working with a number of companies on Hydresia® based Broad Spectrum sunscreens and expect to have the first product launched early in 2012," stated Dr. Jack Guth, VP Research & Development at Botaneco Dr. Guth added, "Hydresia® also allows for less active ingredient to be used in sunscreens, placing a formulation in the highest category of UVA protection possible for labeling purposes. These results are an important step in the Hydresia® oleosome technology achieving worldwide acceptance in SPF sunscreen enhancement." About Hydresia® Hydresia® is a patented plant based material proven to improve the performance, versatility and/or safety of several personal healthcare products including sunscreens, moisturizers, hand sanitizers, shampoos, exfoliants and several daily wear products. Hydresia® is currently used globally in over 150 marketed products and aims to replace chemical emulsifiers in the $117 billion US personal healthcare market. About Botaneco Corp. Botaneco is a global developer and marketer of innovative technologies that help manufacturers meet the consumers growing demand for natural, environmentally friendly, personal healthcare products.  A competitive advantage to Botaneco's patented technology over traditional products in the 'green sector' is the ability to significantly enhance the performance and versatility of these skin and hair care products.  The company has also been awarded the Canadian Agri-Food Award of Excellence for its flaxseed technology marketed in the natural food industry. Botaneco holds patents for its Hydresia® Oleosome, Vegetable Oil Gel, Dermylex® Whey Protein and Flaxseed Dehulling technology. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Botaneco Corp. CONTACT: Murray Bruce Hogan Mullally Chief Financial Investor RelationsOfficer (888) 442-4106Botaneco Corp. hogan@bridge-relations.com(403) 668-4612 www.bridge-relations.combrucem@botaneco.ca

Copyright